Form 8.3 - [Allergan Plc]
March 23 2020 - 10:59AM
Dow Jones News
TIDM0Y7T TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Allergan plc
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.0001 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 20(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 13,686,092 4.15773%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 13,686,092 4.15773%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 300 170.88
-------------- ----------------------------- -----------------------
Purchase 200 170.88
-------------- ----------------------------- -----------------------
Purchase 100 170.88
-------------- ----------------------------- -----------------------
Purchase 119 170.88
-------------- ----------------------------- -----------------------
Purchase 700 170.88
-------------- ----------------------------- -----------------------
Purchase 630 170.88
-------------- ----------------------------- -----------------------
Purchase 500 170.88
-------------- ----------------------------- -----------------------
Purchase 600 170.88
-------------- ----------------------------- -----------------------
Purchase 900 170.88
-------------- ----------------------------- -----------------------
Purchase 900 170.88
-------------- ----------------------------- -----------------------
Purchase 3,400 170.88
-------------- ----------------------------- -----------------------
Purchase 1,500 170.88
-------------- ----------------------------- -----------------------
Purchase 300 170.88
-------------- ----------------------------- -----------------------
Purchase 1,500 170.88
-------------- ----------------------------- -----------------------
Purchase 300 170.88
-------------- ----------------------------- -----------------------
Purchase 3,400 170.88
-------------- ----------------------------- -----------------------
Purchase 700 170.88
-------------- ----------------------------- -----------------------
Purchase 59 170.88
-------------- ----------------------------- -----------------------
Purchase 200 170.88
-------------- ----------------------------- -----------------------
Purchase 900 170.88
-------------- ----------------------------- -----------------------
Purchase 900 170.88
-------------- ----------------------------- -----------------------
Purchase 94 171.44
-------------- ----------------------------- -----------------------
Purchase 500 170.88
-------------- ----------------------------- -----------------------
Purchase 400 170.88
-------------- ----------------------------- -----------------------
Purchase 75,451 170.88
-------------- ----------------------------- -----------------------
Purchase 3,152 170.88
-------------- ----------------------------- -----------------------
Purchase 552 170.88
-------------- ----------------------------- -----------------------
Purchase 115 170.88
-------------- ----------------------------- -----------------------
Purchase 61 171.44
-------------- ----------------------------- -----------------------
Purchase 120 170.88
-------------- ----------------------------- -----------------------
Purchase 126 170.88
-------------- ----------------------------- -----------------------
Purchase 125 170.88
-------------- ----------------------------- -----------------------
Purchase 72 170.88
-------------- ----------------------------- -----------------------
Sale 1,100 170.88
-------------- ----------------------------- -----------------------
Sale 500 170.88
-------------- ----------------------------- -----------------------
Sale 108 170.88
-------------- ----------------------------- -----------------------
Sale 600 170.88
-------------- ----------------------------- -----------------------
Sale 3,400 170.88
-------------- ----------------------------- -----------------------
Sale 200 170.88
-------------- ----------------------------- -----------------------
Sale 900 170.88
-------------- ----------------------------- -----------------------
Sale 200 170.88
-------------- ----------------------------- -----------------------
Sale 900 170.88
-------------- ----------------------------- -----------------------
Sale 1,500 170.88
-------------- ----------------------------- -----------------------
Sale 300 170.88
-------------- ----------------------------- -----------------------
Sale 400 170.88
-------------- ----------------------------- -----------------------
Sale 700 170.88
-------------- ----------------------------- -----------------------
Sale 9 170.88
-------------- ----------------------------- -----------------------
Sale 19,935 170.88
-------------- ----------------------------- -----------------------
Sale 6700 170.88
-------------- ----------------------------- -----------------------
Sale 800 170.88
-------------- ----------------------------- -----------------------
Sale 112 170.88
-------------- ----------------------------- -----------------------
Sale 1,500 170.88
-------------- ----------------------------- -----------------------
Sale 300 170.88
-------------- ----------------------------- -----------------------
Sale 300 170.88
-------------- ----------------------------- -----------------------
Sale 252 170.88
-------------- ----------------------------- -----------------------
Sale 3,400 170.88
-------------- ----------------------------- -----------------------
Sale 700 170.88
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 23(rd) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 23, 2020 10:44 ET (14:44 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024
